Literature DB >> 21801170

Benzodiazepines in the acute management of seizures with autonomic manifestations: anticipate complications!

Laurence Lacroix1, Joel Fluss, Alain Gervaix, Christian M Korff.   

Abstract

The use of rescue benzodiazepines in the management of seizures is widely accepted in emergency pediatric practice. They can, however, cause severe side effects, such as respiratory depression. We describe five patients who presented with severe respiratory depression following benzodiazepine administration for seizures with autonomic manifestations. We also discuss the relationship between the complications observed in our patients and the rescue treatment. A reduction in the dosage of benzodiazepines in the setting of epileptic patients with predominant autonomic symptoms may need to be considered. Wiley Periodicals, Inc.
© 2011 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21801170     DOI: 10.1111/j.1528-1167.2011.03201.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  3 in total

1.  Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy.

Authors:  James W Wheless; Ian Miller; R Edward Hogan; Dennis Dlugos; Victor Biton; Gregory D Cascino; Michael R Sperling; Kore Liow; Blanca Vazquez; Eric B Segal; Daniel Tarquinio; Weldon Mauney; Jay Desai; Adrian L Rabinowicz; Enrique Carrazana
Journal:  Epilepsia       Date:  2021-08-21       Impact factor: 6.740

2.  Panayiotopoulos syndrome presenting with respiratory arrest: A case report and literature review.

Authors:  Maya Dirani; Wissam Yamak; Ahmad Beydoun
Journal:  Epilepsy Behav Case Rep       Date:  2015-02-20

Review 3.  Sleep Related Epilepsy and Pharmacotherapy: An Insight.

Authors:  Jaya Kumar; Amro Solaiman; Pasuk Mahakkanukrauh; Rashidi Mohamed; Srijit Das
Journal:  Front Pharmacol       Date:  2018-09-27       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.